Submitted by Anonymous (not verified) on 21 November 2023 - 11:31
Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Arthritis, Rheumatoid, Date of authorisation: 13/02/2017, Revision: 17, Status: Authorised
Source: